These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6749873)

  • 1. Multiple inverse isotope dilution assay for the stereospecific quantitative determination of R(-) and S(+)-oxaprotiline in biological fluids.
    Dieterle W; Faigle JW
    J Chromatogr; 1982 Jun; 242(2):289-97. PubMed ID: 6749873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple inverse isotope dilution assay for the stereospecific determination of R(+)- and S(-)-oxprenolol in biological fluids.
    Dieterle W; Faigle JW
    J Chromatogr; 1983 Apr; 259(2):311-8. PubMed ID: 6343408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic fate of [14C]oxaprotiline.HCl in man. II. Isolation and identification of metabolites.
    Dieterle W; Faigle JW; Kriemler HP; Winkler T
    Xenobiotica; 1984 Apr; 14(4):311-9. PubMed ID: 6464501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic fate of 14C-oxaprotiline X HCl in man. III. Stereospecific disposition.
    Dieterle W; Faigle JW; Küng W; Theobald W
    Biopharm Drug Dispos; 1984; 5(4):377-86. PubMed ID: 6525444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative high-performance liquid chromatographic assay for the determination of maprotiline and oxaprotiline in human plasma.
    Kuss HJ; Feistenauer E
    J Chromatogr; 1981 Jan; 204():349-53. PubMed ID: 7217264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of maprotiline and oxaprotiline in plasma by high-performance liquid chromatography of fluorescent derivatives.
    Breyer-Pfaff U; Wiatr R; Nill K
    J Chromatogr; 1984 Jul; 309(1):107-14. PubMed ID: 6480757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple inverse isotope dilution assay for cadralazine and four metabolites in biological fluids.
    Schütz H; Faigle JW
    J Chromatogr; 1983 Dec; 281():273-80. PubMed ID: 6365939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation of oxaprotiline: isolation and identification of metabolites in urine of rat and dog.
    Dieterle W; Faigle JW; Kriemler HP; Winkler T
    Xenobiotica; 1986 Aug; 16(8):743-52. PubMed ID: 3765655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple inverse isotope dilution assay for oxprenolol and nine metabolites in biological fluids.
    Dieterle W; Faigle JW
    J Chromatogr; 1983 Apr; 259(2):301-10. PubMed ID: 6343407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of single and repeated doses of maprotiline, oxaprotiline and its enantiomers on foot-shock induced fighting in rats.
    Mogilnicka E; Boissard CG; Waldmeier PC; Delini-Stula A
    Pharmacol Biochem Behav; 1983 Oct; 19(4):719-23. PubMed ID: 6139826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and stereospecific determination of the enantiomers of oxindazac by direct liquid chromatographic resolution on triacetylcellulose.
    Francotte E; Stierlin H; Faigle JW
    J Chromatogr; 1985 Oct; 346():321-31. PubMed ID: 3910671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereospecific assay for (-)- and (+)-propranolol in human and dog plasma.
    Silber B; Riegelman S
    J Pharmacol Exp Ther; 1980 Dec; 215(3):643-8. PubMed ID: 7441523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic fate of [14C]oxaprotiline.HCl in man. I. Disposition and preliminary pharmacokinetics.
    Dieterle W; Faigle JW; Imhof P; Sulc M; Wagner J
    Xenobiotica; 1984 Apr; 14(4):303-10. PubMed ID: 6464500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical studies of the effect of (+) and (-)-oxaprotiline upon noradrenaline uptake.
    Checkley SA; Thompson C; Burton S; Franey C; Arendt J
    Psychopharmacology (Berl); 1985; 87(1):116-8. PubMed ID: 3933029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant-like effects of (+)-oxaprotiline on a behavioral screen.
    Marek GJ; Li A; Seiden LS
    Eur J Pharmacol; 1988 Nov; 157(2-3):183-8. PubMed ID: 3224637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxaprotiline: induction of central noradrenergic subsensitivity of its (+)-enantiomer.
    Mishra R; Gillespie DD; Lovell RA; Robson RD; Sulser F
    Life Sci; 1982 May; 30(20):1747-55. PubMed ID: 6285106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorimetric determination of levoprotiline in human plasma after thin-layer chromatographic or high performance liquid chromatographic separation.
    Horne C; Spahn H; Mutschler E
    Arzneimittelforschung; 1987 Oct; 37(10):1179-81. PubMed ID: 3435591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single treatments with the antidepressant oxaprotiline and its (+) and (-) enantiomers increase behavioural responses to dopaminergic stimulation in the rat.
    Delini-Stula A; Mogilnicka E
    J Neural Transm; 1988; 71(2):91-8. PubMed ID: 3346651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The noradrenaline uptake inhibitor, (+)-oxaprotiline, but not the inactive enantiomer, (-)-oxaprotiline, inhibits sympathetic nerve activity in the rabbit: involvement of adrenoceptors.
    Szabo B; Schultheiss A; Starke K
    Eur J Pharmacol; 1991 Jul; 199(3):325-34. PubMed ID: 1655483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereospecific immuno-recognition of the tetracyclic anti-depressant oxaprotiline.
    Chouchane L; Strosberg AD; Hoebeke J
    Mol Immunol; 1988 Dec; 25(12):1299-308. PubMed ID: 3237214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.